Published in Cancer Weekly, January 2nd, 2007
"Therefore, we investigated whether the response of AML cells to GO treatment also depends on Syk expression. Forty primary AML...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.